Non-coding RNAs and their bioengineering applications for neurological diseases
Engineering of cellular biomolecules is an emerging landscape presenting creative therapeutic opportunities. Recently, several strategies such as biomimetic materials, drug-releasing scaffolds, stem cells, and dynamic culture systems have been developed to improve specific biological functions, howe...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Taylor & Francis Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/86f98868c6e049ffa0772884afa9dac1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:86f98868c6e049ffa0772884afa9dac1 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:86f98868c6e049ffa0772884afa9dac12021-11-11T14:23:43ZNon-coding RNAs and their bioengineering applications for neurological diseases2165-59792165-598710.1080/21655979.2021.2003667https://doaj.org/article/86f98868c6e049ffa0772884afa9dac12021-11-01T00:00:00Zhttp://dx.doi.org/10.1080/21655979.2021.2003667https://doaj.org/toc/2165-5979https://doaj.org/toc/2165-5987Engineering of cellular biomolecules is an emerging landscape presenting creative therapeutic opportunities. Recently, several strategies such as biomimetic materials, drug-releasing scaffolds, stem cells, and dynamic culture systems have been developed to improve specific biological functions, however, have been confounded with fundamental and technical roadblocks. Rapidly emerging investigations on the bioengineering prospects of mammalian ribonucleic acid (RNA) is expected to result in significant biomedical advances. More specifically, the current trend focuses on devising non-coding (nc) RNAs as therapeutic candidates for complex neurological diseases. Given the pleiotropic and regulatory role, ncRNAs such as microRNAs and long non-coding RNAs are deemed as attractive therapeutic candidates. Currently, the list of non-coding RNAs in mammals is evolving, which presents the plethora of hidden possibilities including their current scope in biomedicine. Herein, we critically review on the emerging repertoire of ncRNAs in neurological diseases such as Alzheimer’s disease, Parkinson’s disease, neuroinflammation and drug abuse disorders. Importantly, we present the advances in engineering of ncRNAs to improve their biocompatibility and therapeutic feasibility as well as provide key insights into the applications of bioengineered non-coding RNAs that are investigated for neurological diseases.Tuhin DasTushar Kanti DasAnne KhodarkovskayaSabyasachi DashTaylor & Francis Grouparticlenon-coding rnaneurological disorderbrain functionbioengineeringnon-coding rna therapeuticsgenetic regulationbiomarkerBiotechnologyTP248.13-248.65ENBioengineered, Vol 0, Iss 0 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
non-coding rna neurological disorder brain function bioengineering non-coding rna therapeutics genetic regulation biomarker Biotechnology TP248.13-248.65 |
spellingShingle |
non-coding rna neurological disorder brain function bioengineering non-coding rna therapeutics genetic regulation biomarker Biotechnology TP248.13-248.65 Tuhin Das Tushar Kanti Das Anne Khodarkovskaya Sabyasachi Dash Non-coding RNAs and their bioengineering applications for neurological diseases |
description |
Engineering of cellular biomolecules is an emerging landscape presenting creative therapeutic opportunities. Recently, several strategies such as biomimetic materials, drug-releasing scaffolds, stem cells, and dynamic culture systems have been developed to improve specific biological functions, however, have been confounded with fundamental and technical roadblocks. Rapidly emerging investigations on the bioengineering prospects of mammalian ribonucleic acid (RNA) is expected to result in significant biomedical advances. More specifically, the current trend focuses on devising non-coding (nc) RNAs as therapeutic candidates for complex neurological diseases. Given the pleiotropic and regulatory role, ncRNAs such as microRNAs and long non-coding RNAs are deemed as attractive therapeutic candidates. Currently, the list of non-coding RNAs in mammals is evolving, which presents the plethora of hidden possibilities including their current scope in biomedicine. Herein, we critically review on the emerging repertoire of ncRNAs in neurological diseases such as Alzheimer’s disease, Parkinson’s disease, neuroinflammation and drug abuse disorders. Importantly, we present the advances in engineering of ncRNAs to improve their biocompatibility and therapeutic feasibility as well as provide key insights into the applications of bioengineered non-coding RNAs that are investigated for neurological diseases. |
format |
article |
author |
Tuhin Das Tushar Kanti Das Anne Khodarkovskaya Sabyasachi Dash |
author_facet |
Tuhin Das Tushar Kanti Das Anne Khodarkovskaya Sabyasachi Dash |
author_sort |
Tuhin Das |
title |
Non-coding RNAs and their bioengineering applications for neurological diseases |
title_short |
Non-coding RNAs and their bioengineering applications for neurological diseases |
title_full |
Non-coding RNAs and their bioengineering applications for neurological diseases |
title_fullStr |
Non-coding RNAs and their bioengineering applications for neurological diseases |
title_full_unstemmed |
Non-coding RNAs and their bioengineering applications for neurological diseases |
title_sort |
non-coding rnas and their bioengineering applications for neurological diseases |
publisher |
Taylor & Francis Group |
publishDate |
2021 |
url |
https://doaj.org/article/86f98868c6e049ffa0772884afa9dac1 |
work_keys_str_mv |
AT tuhindas noncodingrnasandtheirbioengineeringapplicationsforneurologicaldiseases AT tusharkantidas noncodingrnasandtheirbioengineeringapplicationsforneurologicaldiseases AT annekhodarkovskaya noncodingrnasandtheirbioengineeringapplicationsforneurologicaldiseases AT sabyasachidash noncodingrnasandtheirbioengineeringapplicationsforneurologicaldiseases |
_version_ |
1718438954331537408 |